Evidence map›Paper›PMID 26493305›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2016

Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.

Luca Donazzan, Felix Mahfoud, Sebastian Ewen, Christian Ukena, Bodo Cremers, Carl-Martin Kirsch, Dirk Hellwig, Tareq Eweiwi, Samer Ezziddin, Murray Esler and 1 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05577208 (Cardiac Sympathetic Neuromodulation by Renal Denervation in Hypertrophic Cardiomyopathy), which is not on this map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05577208 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Cardiac Sympathetic Neuromodulation by Renal Denervation in Hypertrophic Cardiomyopathy (SNYPER Pilot Study)

TypeinterventionalSponsorAdolfo FontenlaRan2022 to 2024Enrolled20ConditionsHypertrophic CardiomyopathyArms"Symplicity Spyral" multi-electrode renal denervation catheter and "Symplicity G3" generator (Renal Denervation System)
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 70 citations in OpenAlex.

  1. Trial
  2. Renal denervation improves exercise blood pressure: insights from a randomized, sham-controlled trial.Clinical research in cardiology : official journal of the German Cardiac Society · 2016
    Trial
  3. Review
  4. Renal denervation for hypertensive heart disease and atrial fibrillation.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Review
  5. Skin sodium content as a predictor of blood pressure response to renal denervation.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Article
  6. Denervation or stimulation? Role of sympatho-vagal imbalance in HFpEF with hypertension.Hypertension research : official journal of the Japanese Society of Hypertension · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Renal sympathetic denervation in patients with vasospastic angina.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020
    Article
  14. Expanding the clinical potential of cardiac radionuclide adrenergic imaging.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020
    Article
  15. Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future.Clinical research in cardiology : official journal of the German Cardiac Society · 2020
    Review
  16. Article
  17. Review
  18. Patient preference for therapies in hypertension: a cross-sectional survey of German patients.Clinical research in cardiology : official journal of the German Cardiac Society · 2019
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Luca DonazzanKlinik für Innere Medizin III (Kardiologie, Angiologie und Internistische Intensivmedizin), Universitätsklinikum des Saarlandes, Kirrberger Str. 1, Geb. 40., 66421, Homburg/Saar, Germany.
Felix MahfoudKlinik für Innere Medizin III (Kardiologie, Angiologie und Internistische Intensivmedizin), Universitätsklinikum des Saarlandes, Kirrberger Str. 1, Geb. 40., 66421, Homburg/Saar, Germany.
Sebastian EwenKlinik für Innere Medizin III (Kardiologie, Angiologie und Internistische Intensivmedizin), Universitätsklinikum des Saarlandes, Kirrberger Str. 1, Geb. 40., 66421, Homburg/Saar, Germany.
Christian UkenaKlinik für Innere Medizin III (Kardiologie, Angiologie und Internistische Intensivmedizin), Universitätsklinikum des Saarlandes, Kirrberger Str. 1, Geb. 40., 66421, Homburg/Saar, Germany.
Bodo CremersKlinik für Innere Medizin III (Kardiologie, Angiologie und Internistische Intensivmedizin), Universitätsklinikum des Saarlandes, Kirrberger Str. 1, Geb. 40., 66421, Homburg/Saar, Germany.
Carl-Martin KirschKlinik für Nuklearmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany.
Dirk HellwigKlinik für Nuklearmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany.
Tareq EweiwiKlinik für Nuklearmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany.
Samer EzziddinKlinik für Nuklearmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany.
Murray EslerBaker IDI Heart and Diabetes Institute, Melbourne, Australia.
Michael BöhmKlinik für Innere Medizin III (Kardiologie, Angiologie und Internistische Intensivmedizin), Universitätsklinikum des Saarlandes, Kirrberger Str. 1, Geb. 40., 66421, Homburg/Saar, Germany. michael.boehm@uniklinikum-saarland.de.
Universitätsklinikum des Saarlandes · DEBaker Heart and Diabetes Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate, whether renal denervation (RDN) has a direct effect on cardiac sympathetic activity and innervation density.

backgroundRDN demonstrated its efficacy not only in reducing blood pressure (BP) in certain patients, but also in decreasing cardiac hypertrophy and arrhythmias. These pleiotropic effects occur partly independent from the observed BP reduction.

methodsEleven patients with resistant hypertension (mean office systolic BP 180 ± 18 mmHg, mean antihypertensive medications 6.0 ± 1.5) underwent I-123-mIBG scintigraphy to exclude pheochromocytoma. We measured cardiac sympathetic innervation and activity before and 9 months after RDN. Cardiac sympathetic innervation was assessed by heart to mediastinum ratio (H/M) and sympathetic activity by wash out ratio (WOR). Effects on office BP, 24 h ambulatory BP monitoring, were documented.

resultsOffice systolic BP and mean ambulatory systolic BP were significantly reduced from 180 to 141 mmHg (p = 0.006) and from 149 to 129 mmHg (p = 0.014), respectively. Cardiac innervation remained unchanged before and after RDN (H/M 2.5 ± 0.5 versus 2.6 ± 0.4, p = 0.285). Cardiac sympathetic activity was significantly reduced by 67 % (WOR decreased from 24.1 ± 12.7 to 7.9 ± 25.3 %, p = 0.047). Both, responders and non-responders experienced a reduction of cardiac sympathetic activity.

conclusionRDN significantly reduced cardiac sympathetic activity thereby demonstrating a direct effect on the heart. These changes occurred independently from BP effects and provide a pathophysiological basis for studies, investigating the potential effect of RDN on arrhythmias and heart failure.

Indexed as

Catheter Ablation3-IodobenzylguanidineAgedAntihypertensive AgentsBlood PressureBlood Pressure Monitoring, AmbulatoryDrug ResistanceFemaleHeartHumansHypertensionKidneyMaleMiddle AgedRadiopharmaceuticalsRecurrence3-IodobenzylguanidineAntihypertensive AgentsRadiopharmaceuticalsArrhythmiasHeart failureMIBGRenal denervationResistant hypertension

Identifiers

PMID26493305
OpenAlexW2196252002

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.